Cutera (NASDAQ:CUTR) posted its earnings results on Thursday. The medical device company reported $0.15 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.23, Briefing.com reports. The company had revenue of $46.12 million during the quarter, compared to analyst estimates of $41.66 million. Cutera had a negative return on equity of 69.92% and a negative net margin of 20.49%. The business’s revenue was up 13.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.11 earnings per share.
Shares of NASDAQ CUTR traded up $3.75 during trading on Friday, hitting $36.28. The company had a trading volume of 764,700 shares, compared to its average volume of 170,393. The company has a market cap of $466.84 million, a P/E ratio of -16.27 and a beta of 0.88. Cutera has a 52 week low of $12.32 and a 52 week high of $38.88. The business’s 50-day moving average is $30.12 and its 200 day moving average is $24.67. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.16 and a current ratio of 1.67.
Several equities analysts have recently commented on the company. BidaskClub raised Cutera from a “buy” rating to a “strong-buy” rating in a report on Tuesday, November 5th. Maxim Group reaffirmed a “hold” rating on shares of Cutera in a report on Friday, August 9th. Stephens boosted their price objective on Cutera from $35.00 to $45.00 and gave the stock an “overweight” rating in a research report on Friday. Zacks Investment Research upgraded Cutera from a “hold” rating to a “buy” rating and set a $35.00 price objective for the company in a research report on Tuesday, October 29th. Finally, Sidoti downgraded Cutera from a “buy” rating to a “neutral” rating in a research report on Thursday, August 22nd. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $40.00.
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.